Abbott Laboratories News

“Researchers from around the world have requested to study Abbott's Bcl-2 family protein inhibitors, which is an indication of the potential value that ABT-263 might bring to the cancer research field”

Both compounds were discovered by Abbott scientists and are being co-developed by Abbott and Genentech. via Earth Times

Comment?

“We continue to be pleased with the way XIENCE V is performing, with outstanding results that are consistent with what we have seen throughout the SPIRIT III trial.”

From correspondents in Delhi, India, 12:08 PM IST Long-term data presented for the first time today from the SPIRIT III trial, Abbott's U.S. pivotal trial studying the XIENCE V Everolimus Eluting Coronary Stent ... via India eNews

Comment?

The granddaddy of monthly economic reports is the federal reading on the employment situation. via Fox News

Comment?

Access to some antiretroviral drugs is increasing in Thailand because of the country's decision to issue compulsory licenses for certain medications, Winai Sawasdiworn, deputy secretary-general of the National ... via MediLexicon

Comment?

It's a fairly quiet day in analyst land as far as the most active stocks are concerned, despite there being many movers today. via Blogging Stocks

Comment?

Dr. Garcia, technical support senior scientist,, she is responsible for managing products, managing product investigations, transfers and launches, and working on projects that support liability issues. via Press Release News From 24-7 Press Re...

Comment?

For a long time, few drugs were developed for rheumatological diseases. It was considered unattractive from a commercial viewpoint since relatively few patients suffered from them. via The Biotech Stock Blog

Comment?

“Accumulating, summarizing and auditing this information will take more time than for any other current disclosure requirement”

Executives at Eli Lilly & Co. and Abbott Laboratories criticized FASB's proposal to require more detailed disclosure of the investment allocation and valuation of pension assets, calling it excessive and ... via Pensions & Investments

Comment?

Dear Scott: In one of your columns you mentioned that selling Abbott in a retirement account would have no tax consequence. via News-Sun

Comment?

OSAKA, Japan, and ABBOTT PARK, Ill., May 1 /PRNewswire-FirstCall/ -- Abbott and Takeda Pharmaceutical Company Limited have concluded their TAP Pharmaceutical Products Inc. via BioSpace

Comment?